Eltrombopag-related renal vein thromboembolism in a patient with immune thrombocytopenia: A case report

BACKGROUND: Eltrombopag is an orally administered thrombopoietin receptor agonist linked to a heightened risk of treatment-related thromboembolism. Both venous and arterial thromboses have been documented in the medical literature. CASE SUMMARY: In the absence of nephropathy, a 48-year-old patient r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Cen, Zhou, Xiao-Ming, Liu, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040189/
https://www.ncbi.nlm.nih.gov/pubmed/33889627
http://dx.doi.org/10.12998/wjcc.v9.i11.2611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040189/
https://www.ncbi.nlm.nih.gov/pubmed/33889627
http://dx.doi.org/10.12998/wjcc.v9.i11.2611

Ejemplares similares